First Ascent Biomedical Secures $6 Million Investment From Vidal Duart Enterprises, Techstars
January 24, 2025
January 24, 2025
NEW YORK, Jan. 24 -- Pillsbury, a law firm, issued the following news release:
Pillsbury advised First Ascent Biomedical, a pioneer in personalized cancer treatment, in securing a $6 million investment from Vidal Duart Enterprises, Inc., with an additional co-investment from Techstars.
Leveraging advanced technologies to personalize cancer treatment, First Ascent Biomedical's platform has been shown to significantly outperform standard care, offering a new frontier . . .
Pillsbury advised First Ascent Biomedical, a pioneer in personalized cancer treatment, in securing a $6 million investment from Vidal Duart Enterprises, Inc., with an additional co-investment from Techstars.
Leveraging advanced technologies to personalize cancer treatment, First Ascent Biomedical's platform has been shown to significantly outperform standard care, offering a new frontier . . .